Razmjoo Sasan, Shahbazian Hodjatollah, Hosseini Seyed-Mohammad, Feli Maryam, Mohammadian Fatemeh, Bagheri Ali
Department of Clinical Oncology and Clinical Research Development Center, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Interventional Radiotherapy Ward, Department of Radiation Oncology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Brachytherapy. 2023 May-Jun;22(3):389-399. doi: 10.1016/j.brachy.2023.01.004. Epub 2023 Mar 14.
Granulation tissue-induced tracheal stenosis (mainly secondary to intubation or lung transplantation) is one of the most common etiologies of benign airway obstructions. Recurrence rates after standard treatment options (surgical resection and/or endobronchial interventions) can inadvertently worsen the stricture through the stimulation of more granulation tissue generation (via increased fibroblast activity and roliferation). Low-dose radiotherapy could be a promising tool to prevent granulation tissue formation after surgery and/or endobronchial interventions regarding its established role in the treatment of keloids or hypertrophic scars, two benign diseases with similar a pathophysiology to tracheal stenosis. This study reviews case reports and small series that used endobronchial brachytherapy (EBBT) or external beam radiotherapy (EBRT) for the management of refractory granulation tissue-induced tracheal stenosis after surgery and/or endobronchial interventions.
Case reports and series (published up to October 2022) that reported outcomes of patients with recurrent granulation tissue-induced tracheal stenosis (after surgery and/or endobronchial interventions) treated by EBBT or EBRT (in definitive or prophylactic settings) were eligible.
Sixteen studies (EBBT: nine studies including 69 patients, EBRT: seven studies including 32 patients) were reviewed. The pooled success rate across all studies was 74% and 97% for EBBT and EBRT, respectively.
Radiation therapy appears to be effective in the management of selected patients with recurrent/refractory tracheal stenosis. Response to this treatment is usually good, but further studies with a larger number of patients and long-term followup are necessary to determine the optimal technique, dose, and timing of radiation therapy, late complications, the durability of response, and criteria for patient selection.
肉芽组织诱导的气管狭窄(主要继发于插管或肺移植)是良性气道阻塞最常见的病因之一。标准治疗方案(手术切除和/或支气管内介入)后的复发率可能会因刺激更多肉芽组织生成(通过增加成纤维细胞活性和增殖)而无意中加重狭窄。低剂量放疗在治疗瘢痕疙瘩或肥厚性瘢痕(两种与气管狭窄病理生理相似的良性疾病)方面已确立了作用,可能是预防手术和/或支气管内介入后肉芽组织形成的一种有前景的工具。本研究回顾了使用支气管内近距离放疗(EBBT)或外照射放疗(EBRT)治疗手术和/或支气管内介入后难治性肉芽组织诱导的气管狭窄的病例报告和小系列研究。
符合条件的病例报告和系列研究(截至2022年10月发表),报告了复发性肉芽组织诱导的气管狭窄患者(手术和/或支气管内介入后)接受EBBT或EBRT(在确定性或预防性设置中)治疗的结果。
回顾了16项研究(EBBT:9项研究,包括69例患者;EBRT:7项研究,包括32例患者)。所有研究中EBBT和EBRT的综合成功率分别为74%和97%。
放射治疗似乎对部分复发性/难治性气管狭窄患者有效。这种治疗的反应通常良好,但需要更多患者的进一步研究和长期随访,以确定放疗的最佳技术、剂量和时机、晚期并发症、反应的持久性以及患者选择标准。